BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36089117)

  • 1. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma.
    Zhu Z; Kiang KM; Li N; Liu J; Zhang P; Jin L; He X; Zhang S; Leung GK
    Cancer Lett; 2022 Nov; 549():215903. PubMed ID: 36089117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
    Koufaris C; Gallage S; Yang T; Lau CH; Valbuena GN; Keun HC
    J Proteome Res; 2016 Aug; 15(8):2618-25. PubMed ID: 27315223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
    Nishimura T; Nakata A; Chen X; Nishi K; Meguro-Horike M; Sasaki S; Kita K; Horike SI; Saitoh K; Kato K; Igarashi K; Murayama T; Kohno S; Takahashi C; Mukaida N; Yano S; Soga T; Tojo A; Gotoh N
    Oncogene; 2019 Apr; 38(14):2464-2481. PubMed ID: 30532069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism.
    Zhang F; Wang D; Li J; Su Y; Liu S; Lei QY; Yin M
    J Mol Cell Biol; 2022 Jul; 14(4):. PubMed ID: 35349697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.
    Li G; Wu J; Li L; Jiang P
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
    Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
    Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.
    Green NH; Galvan DL; Badal SS; Chang BH; LeBleu VS; Long J; Jonasch E; Danesh FR
    Oncogene; 2019 Aug; 38(34):6211-6225. PubMed ID: 31289360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma cells require one-carbon metabolism to survive glutamine starvation.
    Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
    Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.
    Bonagas N; Gustafsson NMS; Henriksson M; Marttila P; Gustafsson R; Wiita E; Borhade S; Green AC; Vallin KSA; Sarno A; Svensson R; Göktürk C; Pham T; Jemth AS; Loseva O; Cookson V; Kiweler N; Sandberg L; Rasti A; Unterlass JE; Haraldsson M; Andersson Y; Scaletti ER; Bengtsson C; Paulin CBJ; Sanjiv K; Abdurakhmanov E; Pudelko L; Kunz B; Desroses M; Iliev P; Färnegårdh K; Krämer A; Garg N; Michel M; Häggblad S; Jarvius M; Kalderén C; Jensen AB; Almlöf I; Karsten S; Zhang SM; Häggblad M; Eriksson A; Liu J; Glinghammar B; Nekhotiaeva N; Klingegård F; Koolmeister T; Martens U; Llona-Minguez S; Moulson R; Nordström H; Parrow V; Dahllund L; Sjöberg B; Vargas IL; Vo DD; Wannberg J; Knapp S; Krokan HE; Arvidsson PI; Scobie M; Meiser J; Stenmark P; Berglund UW; Homan EJ; Helleday T
    Nat Cancer; 2022 Feb; 3(2):156-172. PubMed ID: 35228749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.
    Nilsson R; Jain M; Madhusudhan N; Sheppard NG; Strittmatter L; Kampf C; Huang J; Asplund A; Mootha VK
    Nat Commun; 2014; 5():3128. PubMed ID: 24451681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
    Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
    J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy.
    Yang C; Zhang J; Liao M; Yang Y; Wang Y; Yuan Y; Ouyang L
    Drug Discov Today; 2021 Mar; 26(3):817-825. PubMed ID: 33316375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newcastle Disease Virus Manipulates Mitochondrial MTHFD2-Mediated Nucleotide Metabolism for Virus Replication.
    Tang N; Chen P; Zhao C; Liu P; Tan L; Song C; Qiu X; Liao Y; Liu X; Luo T; Sun Y; Ding C
    J Virol; 2023 Mar; 97(3):e0001623. PubMed ID: 36794935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy.
    Cheung CHY; Hsu CL; Tsuei CY; Kuo TT; Huang CT; Hsu WM; Chung YH; Wu HY; Hsu CC; Huang HC; Juan HF
    Cell Death Dis; 2019 Oct; 10(11):786. PubMed ID: 31624245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting MTHFD2 to Exploit Cancer-Specific Metabolism and the DNA Damage Response.
    Ramos L; Henriksson M; Helleday T; Green AC
    Cancer Res; 2024 Jan; 84(1):9-16. PubMed ID: 37922465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin inhibits SIRT3-deacetylation MTHFD2 to disturb cellular redox balance in colorectal cancer cell.
    Wan X; Wang C; Huang Z; Zhou D; Xiang S; Qi Q; Chen X; Arbely E; Liu CY; Du P; Yu W
    Cell Death Dis; 2020 Aug; 11(8):649. PubMed ID: 32811824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer.
    Nilsson R; Nicolaidou V; Koufaris C
    Gene; 2019 Oct; 716():144032. PubMed ID: 31377316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
    Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
    J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway.
    Li Q; Yang F; Shi X; Bian S; Shen F; Wu Y; Zhu C; Fu F; Wang J; Zhou J; Chen Y
    FEBS Open Bio; 2021 Oct; 11(10):2845-2857. PubMed ID: 34231329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2).
    Lee LC; Peng YH; Chang HH; Hsu T; Lu CT; Huang CH; Hsueh CC; Kung FC; Kuo CC; Jiaang WT; Wu SY
    J Med Chem; 2021 Aug; 64(15):11288-11301. PubMed ID: 34337952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.